{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T11:49:57Z","timestamp":1766576997149,"version":"3.48.0"},"reference-count":68,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:00:00Z","timestamp":1766534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Neurodegenerative synucleinopathies\u2014including Parkinson\u2019s disease, multiple system atrophy, pure autonomic failure, and dementia with Lewy bodies\u2014often feature cardiovascular autonomic dysfunction. Neurogenic orthostatic hypotension (nOH) is common and symptomatic, while neurogenic supine hypertension (nSH) is less frequent but may carry long-term cardiovascular risks. Lifestyle measures are first-line for managing nSH, yet persistent hypertension unresponsive to nonpharmacological strategies presents a treatment dilemma. Limited trial data and unclear guidelines make it difficult to determine when antihypertensive therapy is appropriate. Evidence from studies on hypertension-mediated organ damage (HMOD)\u2014assessed through markers such as carotid intima-media thickness, pulse wave velocity, left ventricular hypertrophy, estimated glomerular filtration rate, and white matter hyperintensities\u2014suggests that nSH, rather than the underlying neurodegenerative disorder, drives vascular, cardiac, renal, and cerebral injury. Therefore, treatment decisions should be individualized. While antihypertensive therapy may help prevent subclinical organ damage, clinicians must balance this benefit against the risk of worsening nOH and further compromising overall prognosis.<\/jats:p>","DOI":"10.3390\/biomedicines14010040","type":"journal-article","created":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T11:22:14Z","timestamp":1766575334000},"page":"40","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Should Neurogenic Supine Hypertension Be Treated? Insights from Hypertension-Mediated Organ Damage Studies\u2014A Narrative Review"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8910-7378","authenticated-orcid":false,"given":"Cristiano","family":"Fava","sequence":"first","affiliation":[{"name":"Section of General Medicine C, Department of Medicine, University and Azienda Ospedaliera Universitaria Integrata of Verona, 37126 Verona, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Stocchetti","sequence":"additional","affiliation":[{"name":"Section of General Medicine C, Department of Medicine, University and Azienda Ospedaliera Universitaria Integrata of Verona, 37126 Verona, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Bonafini","sequence":"additional","affiliation":[{"name":"Section of General Medicine C, Department of Medicine, University and Azienda Ospedaliera Universitaria Integrata of Verona, 37126 Verona, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,12,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41582-024-01043-w","article-title":"\u03b1-Synuclein Pathology as a Target in Neurodegenerative Diseases","volume":"21","author":"Park","year":"2025","journal-title":"Nat. Rev. Neurol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s10286-015-0336-4","article-title":"Supine Hypertension in Parkinson\u2019s Disease and Multiple System Atrophy","volume":"26","author":"Fanciulli","year":"2016","journal-title":"Clin. Auton. Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1007\/s00415-016-8375-x","article-title":"The Recommendations of a Consensus Panel for the Screening, Diagnosis, and Treatment of Neurogenic Orthostatic Hypotension and Associated Supine Hypertension","volume":"264","author":"Gibbons","year":"2017","journal-title":"J. Neurol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1097\/HJH.0000000000004053","article-title":"Nocturnal Blood Pressure: Pathophysiology, Measurement and Clinical Implications. Position Paper of the European Society of Hypertension","volume":"43","author":"Parati","year":"2025","journal-title":"J. Hypertens."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1097\/HJH.0000000000003480","article-title":"2023 ESH Guidelines for the Management of Arterial Hypertension The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA)","volume":"41","author":"Mancia","year":"2023","journal-title":"J. Hypertens."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1097\/HJH.0000000000000221","article-title":"European Society of Hypertension Practice Guidelines for Ambulatory Blood Pressure Monitoring","volume":"32","author":"Parati","year":"2014","journal-title":"J. Hypertens."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s11906-022-01168-7","article-title":"Advances in the Pathophysiology and Management of Supine Hypertension in Patients with Neurogenic Orthostatic Hypotension","volume":"24","author":"Park","year":"2022","journal-title":"Curr. Hypertens. Rep."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1002\/mds.25898","article-title":"Mortality in Parkinson\u2019s Disease: A Systematic Review and Meta-Analysis","volume":"29","author":"Macleod","year":"2014","journal-title":"Mov. Disord."},{"key":"ref_9","first-page":"101078","article-title":"Disease Burden of Parkinson\u2019s Disease in China and Its Provinces from 1990 to 2021: Findings from the Global Burden of Disease Study 2021","volume":"46","author":"Xu","year":"2024","journal-title":"Lancet Reg. Health West Pac."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Ryu, D.-W., Han, K., and Cho, A.-H. (2023). Mortality and Causes of Death in Patients with Parkinson\u2019s Disease: A Nationwide Population-Based Cohort Study. Front. Neurol., 14.","DOI":"10.3389\/fneur.2023.1236296"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41531-022-00320-z","article-title":"Parkinson\u2019s Disease Clinical Milestones and Mortality","volume":"8","author":"Gonzalez","year":"2022","journal-title":"NPJ Park. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1017\/S0033291713000494","article-title":"The Prevalence and Incidence of Dementia with Lewy Bodies: A Systematic Review of Population and Clinical Studies","volume":"44","year":"2014","journal-title":"Psychol. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10286-023-00933-1","article-title":"Orthostatic Hypotension in Dementia with Lewy Bodies: A Meta-Analysis of Prospective Studies","volume":"33","author":"Isik","year":"2023","journal-title":"Clin. Auton. Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S1474-4422(03)00662-8","article-title":"Multiple System Atrophy","volume":"3","author":"Wenning","year":"2004","journal-title":"Lancet Neurol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1136\/jnnp-2012-302500","article-title":"Incidence and Prevalence of Multiple System Atrophy: A Nationwide Study in Iceland","volume":"84","author":"Bjornsdottir","year":"2013","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/S0140-6736(99)04137-9","article-title":"Prevalence of Progressive Supranuclear Palsy and Multiple System Atrophy: A Cross-Sectional Study","volume":"354","author":"Schrag","year":"1999","journal-title":"Lancet"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e889","DOI":"10.1212\/WNL.0000000000010002","article-title":"Predicting Phenoconversion in Pure Autonomic Failure","volume":"95","author":"Coon","year":"2020","journal-title":"Neurology"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1212\/01.wnl.0000303818.38960.44","article-title":"Use of Antihypertensives and the Risk of Parkinson Disease","volume":"70","author":"Becker","year":"2008","journal-title":"Neurology"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000054770","article-title":"Risk Factors for Parkinson\u2019s Disease: The Leisure World Cohort Study","volume":"20","year":"2001","journal-title":"Neuroepidemiology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.parkreldis.2005.09.004","article-title":"Diabetes, Smoking, and Other Medical Conditions in Relation to Parkinson\u2019s Disease Risk","volume":"12","author":"Powers","year":"2006","journal-title":"Park. Relat. Disord."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s41531-021-00202-w","article-title":"Case-Control Study of Hypertension and Parkinson\u2019s Disease","volume":"7","author":"Ng","year":"2021","journal-title":"NPJ Park. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10286-015-0324-8","article-title":"Clinical Characteristics of Supine Hypertension in de Novo Parkinson Disease","volume":"26","author":"Umehara","year":"2016","journal-title":"Clin. Auton. Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s10286-015-0307-9","article-title":"Residual Sympathetic Tone Is Associated with Reduced Insulin Sensitivity in Patients with Autonomic Failure","volume":"25","author":"Celedonio","year":"2015","journal-title":"Clin. Auton. Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"102988","DOI":"10.1016\/j.autneu.2022.102988","article-title":"Supine Hypertension: A State of the Art","volume":"241","author":"Mantovani","year":"2022","journal-title":"Auton. Neurosci."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Tulb\u0103, D., Cozma, L., B\u0103l\u0103nescu, P., Buzea, A., B\u0103icu\u0219, C., and Popescu, B.O. (2021). Blood Pressure Patterns in Patients with Parkinson\u2019s Disease: A Systematic Review. J. Pers. Med., 11.","DOI":"10.3390\/jpm11020129"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Hou, L., Li, Q., Jiang, L., Qiu, H., Geng, C., Hong, J.-S., Li, H., and Wang, Q. (2018). Hypertension and Diagnosis of Parkinson\u2019s Disease: A Meta-Analysis of Cohort Studies. Front. Neurol., 9.","DOI":"10.3389\/fneur.2018.00162"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41531-023-00546-5","article-title":"A 3-Year Natural History of Orthostatic Blood Pressure Dysregulation in Early Parkinson\u2019s Disease","volume":"9","author":"Yoo","year":"2023","journal-title":"NPJ Park. Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1002\/mdc3.70142","article-title":"Prevalence of Supine Hypertension in Alpha-Synucleinopathies: A Systematic Review and Meta-Analysis","volume":"12","author":"Arca","year":"2025","journal-title":"Mov. Disord. Clin. Pract."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1124\/pr.115.012161","article-title":"The Pharmacology of Autonomic Failure: From Hypotension to Hypertension","volume":"69","author":"Biaggioni","year":"2017","journal-title":"Pharmacol. Rev."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1161\/HYPERTENSIONAHA.111.00377","article-title":"Angiotensin II, Independent of Plasma Renin Activity, Contributes to the Hypertension of Autonomic Failure","volume":"61","author":"Arnold","year":"2013","journal-title":"Hypertension"},{"key":"ref_31","first-page":"580","article-title":"Hyporeninemic Normoaldosteronism in Severe Autonomic Failure","volume":"76","author":"Biaggioni","year":"1993","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1161\/HYPERTENSIONAHA.115.06617","article-title":"Mineralocorticoid Receptor Activation Contributes to the Supine Hypertension of Autonomic Failure","volume":"67","author":"Arnold","year":"2016","journal-title":"Hypertension"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1161\/HYPERTENSIONAHA.107.105171","article-title":"Excessive Nitric Oxide Function and Blood Pressure Regulation in Patients with Autonomic Failure","volume":"51","author":"Gamboa","year":"2008","journal-title":"Hypertension"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1002\/mds.21757","article-title":"Carotid Intima-Media Thickness in Parkinson\u2019s Disease","volume":"22","author":"Lee","year":"2007","journal-title":"Mov. Disord."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1007\/s10072-016-2660-4","article-title":"Parkinson\u2019s Disease and Cerebrovascular Disease: Is There a Link? A Neurosonological Case-Control Study","volume":"37","author":"Gioulis","year":"2016","journal-title":"Neurol. Sci."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1111\/ene.14938","article-title":"Cardiovascular and Cerebrovascular Risk Markers in Parkinson\u2019s Disease: Results from a Case-Control Study","volume":"28","author":"Alves","year":"2021","journal-title":"Eur. J. Neurol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"94","DOI":"10.21037\/atm.2019.01.68","article-title":"Association between Carotid Plaque and Parkinson\u2019s Disease","volume":"7","author":"Yan","year":"2019","journal-title":"Ann. Transl. Med."},{"key":"ref_38","first-page":"52","article-title":"Parkinson\u2019s Disease and Carotid Intima-Media Thickness","volume":"118","author":"Alexa","year":"2014","journal-title":"Rev. Med. Chir. Soc. Med. Nat. Iasi."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1002\/mds.25066","article-title":"Impairment of Brain Vessels May Contribute to Mortality in Patients with Parkinson\u2019s Disease","volume":"27","author":"Rektor","year":"2012","journal-title":"Mov. Disord."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1161\/HYPERTENSIONAHA.115.05913","article-title":"Cardiac Organ Damage and Arterial Stiffness in Autonomic Failure: Comparison With Essential Hypertension","volume":"66","author":"Milazzo","year":"2015","journal-title":"Hypertension"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1080\/10641963.2021.2001480","article-title":"Analysis of Cardiovascular Hemodynamic and Autonomic Variables in Individuals with Systemic Arterial Hypertension, Type 2 Diabetes Mellitus, and Parkinson\u2019s Disease: A Comparative Study","volume":"44","author":"Fernandes","year":"2022","journal-title":"Clin. Exp. Hypertens."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"135","DOI":"10.14802\/jmd.17035","article-title":"A Comparative Study of Central Hemodynamics in Parkinson\u2019s Disease","volume":"10","author":"Park","year":"2017","journal-title":"J. Mov. Disord."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000450613","article-title":"Arterial Stiffness and Cardiovascular Autonomic Dysfunction in Patients with Parkinson\u2019s Disease","volume":"17","author":"Kim","year":"2017","journal-title":"Neurodegener. Dis."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2169\/internalmedicine.53.1043","article-title":"Parkinson\u2019s Disease and the Cardio-Ankle Vascular Stiffness Index","volume":"53","author":"Suzuki","year":"2014","journal-title":"Intern. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00415-016-8352-4","article-title":"Central Hemodynamics and Arterial Stiffness in Idiopathic and Multiple System Atrophy","volume":"264","author":"Franzen","year":"2017","journal-title":"J. Neurol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.4103\/0028-3886.391388","article-title":"Study on the Correlation between Blood Urea Nitrogen, Creatinine Level, Proteinuria and Parkinson\u2019s Disease","volume":"71","author":"Yang","year":"2023","journal-title":"Neurol. India"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1002\/mds.27704","article-title":"Chronic Renal Dysfunction, Proteinuria, and Risk of Parkinson\u2019s Disease in the Elderly","volume":"34","author":"Nam","year":"2019","journal-title":"Mov. Disord."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1161\/HYPERTENSIONAHA.109.136853","article-title":"Renal Impairment of Pure Autonomic Failure","volume":"54","author":"Garland","year":"2009","journal-title":"Hypertension"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Peng, H., Wu, L., Chen, Q., Chen, S., Wu, S., Shi, X., Ma, J., Yang, H., and Li, X. (2024). Association between Kidney Function and Parkinson\u2019s Disease Risk: A Prospective Study from the UK Biobank. BMC Public Health, 24.","DOI":"10.1186\/s12889-024-19709-x"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Kwon, M.J., Kim, J.-K., Kim, J.H., Kim, J.-H., Kim, M.-J., Kim, N.Y., Choi, H.G., and Kim, E.S. (2023). Exploring the Link between Chronic Kidney Disease and Parkinson\u2019s Disease: Insights from a Longitudinal Study Using a National Health Screening Cohort. Nutrients, 15.","DOI":"10.3390\/nu15143205"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.parkreldis.2020.04.011","article-title":"The Impact of Supine Hypertension on Target Organ Damage and Survival in Patients with Synucleinopathies and Neurogenic Orthostatic Hypotension","volume":"75","author":"Palma","year":"2020","journal-title":"Park. Relat. Disord."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1007\/s00415-009-5176-5","article-title":"White Matter Hyperintensities in Patients with Multiple System Atrophy","volume":"256","author":"Lim","year":"2009","journal-title":"J. Neurol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1148\/radiol.10090988","article-title":"Microstructural White Matter Abnormalities of Multiple System Atrophy: In Vivo Topographic Illustration by Using Diffusion-Tensor MR Imaging","volume":"255","author":"Tha","year":"2010","journal-title":"Radiology"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.parkreldis.2011.08.004","article-title":"White Matter Hyperintensities in Patients with Multiple System Atrophy","volume":"18","author":"Umoto","year":"2012","journal-title":"Park. Relat. Disord."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"811","DOI":"10.3109\/07420528.2013.766618","article-title":"Nighttime Blood Pressure and White Matter Hyperintensities in Patients with Parkinson Disease","volume":"30","author":"Oh","year":"2013","journal-title":"Chronobiol. Int."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jns.2016.01.061","article-title":"Association between Urine Protein\/Creatinine Ratio and Cognitive Dysfunction in Lewy Body Disorders","volume":"362","author":"Oh","year":"2016","journal-title":"J. Neurol. Sci."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1007\/s10072-025-08029-6","article-title":"Nighttime Systolic Blood Pressure Reduction Rate and Periventricular White Matter Hyperintensity Were Associated with Cognitive Function in Parkinson\u2019s Disease","volume":"46","author":"Chen","year":"2025","journal-title":"Neurol. Sci."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.amjhyper.2006.02.016","article-title":"Left Ventricular Hypertrophy in Patients with Autonomic Failure","volume":"19","author":"Maule","year":"2006","journal-title":"Am. J. Hypertens."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S0140-6736(99)05320-9","article-title":"Hypertensive Cardiovascular Damage in Patients with Primary Autonomic Failure","volume":"355","author":"Vagaonescu","year":"2000","journal-title":"Lancet"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/HJH.0000000000002249","article-title":"Cardiac Organ Damage in Patients with Parkinson\u2019s Disease and Reverse Dipping","volume":"38","author":"Sobrero","year":"2020","journal-title":"J. Hypertens."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1080\/01616412.2017.1390933","article-title":"Structural and Functional Alterations of the Heart in Parkinson\u2019s Disease","volume":"40","year":"2018","journal-title":"Neurol. Res."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/HJH.0b013e32834f09ee","article-title":"Aortic Augmentation Index and Pulse Wave Velocity in Response to Head-up Tilting: Effect of Autonomic Failure","volume":"30","author":"Huijben","year":"2012","journal-title":"J. Hypertens."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1055\/a-1529-6480","article-title":"Acute Cardiovascular Responses to Self-Selected Intensity Exercise in Parkinson\u2019s Disease","volume":"43","author":"Kanegusuku","year":"2022","journal-title":"Int. J. Sports Med."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1161\/HYPERTENSIONAHA.122.20081","article-title":"Continuous Positive Airway Pressure for the Treatment of Supine Hypertension and Orthostatic Hypotension in Autonomic Failure","volume":"80","author":"Okamoto","year":"2023","journal-title":"Hypertension"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"e018979","DOI":"10.1161\/JAHA.120.018979","article-title":"Local Passive Heat for the Treatment of Hypertension in Autonomic Failure","volume":"10","author":"Okamoto","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s10286-025-01131-x","article-title":"Peripheral Autonomic Failure Is Associated with More Severe Postprandial Hypotension Compared to Central Autonomic Failure","volume":"35","author":"Mehr","year":"2025","journal-title":"Clin. Auton. Res."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1093\/eurheartj\/ehae178","article-title":"2024 ESC Guidelines for the Management of Elevated Blood Pressure and Hypertension","volume":"45","author":"McEvoy","year":"2024","journal-title":"Eur. Heart J."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.jacc.2025.05.007","article-title":"2025 AHA\/ACC\/AANP\/AAPA\/ABC\/ACCP\/ACPM\/AGS\/AMA\/ASPC\/NMA\/PCNA\/SGIM Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults","volume":"86","author":"Jones","year":"2025","journal-title":"JACC"}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/14\/1\/40\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T11:49:15Z","timestamp":1766576955000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/14\/1\/40"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,24]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["biomedicines14010040"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines14010040","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,24]]}}}